“The loss of hair that comes as a side effect of many chemotherapy agents can be a devastating part of cancer treatment. Some patients see it as not just a blow to their vanity but as a constant, visual reminder of their illness. It’s often the most devastating aspect of treatment.” – Hope S. Rugo, MD

CLINICAL RESOURCES DIGNICAP DELTA

Hair loss can be one of the most devastating side effects for cancer patients undergoing chemotherapy. Scalp cooling, sometimes known as cold caps, is an effective method to greatly reduce chemotherapy-induced alopecia in cancer patients with solid tumors.

Our Clinical Support team is here to help you build a successful scalp cooling program at your facility. If you have any questions contact us HERE.

“For those of us who have been giving chemo for so long, to see that finally there is something to provide confidence to patients is exciting. When you can offer this, the world changes. You see it in our patients’ whole outlook as they deal with cancer.” – Marta Vallee-Cobham, RN

TRAINING

If you are a clinician at a facility that currently offers DigniCap Delta, log in to view training materials.

DIGNICAP C3 TRAINING

CLINICAL RESEARCH

CLICK HERE for a detailed overview of clinical research on The DigniCap Scalp Cooling System.

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 877-350-2150

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

DISTRIBUTOR
Aurora BioScience
PO Box 946
Baulkham Hills NSW 2153
+61 1300 309 994
+64 0800 533 272